Centessa Pharmaceuticals plc

CNTA · Healthcare · Centessa Pharmaceuticals plc, together with its subsidiaries, discovers, develops, and delivers orexin-based neuroscience therapeutics in t…

Centessa Pharmaceuticals plc (CNTA), in the Healthcare sector, has 17 disclosed filings on Paydirt over the trailing twelve months from 7 corporate insiders: 0 purchases and 17 sales. Filers took a median of 0 days from execution to disclosure, and the most recent trade was executed Jun 24 and filed Jun 24. The most active filer was Gregory M Weinhoff with 13 filings.

Add to watchlist

Filings, ttm

0 buys · 17 sells

Traders, ttm

7 insiders

Volume, ttmiDollar value disclosed in the window

$1.2B

estimated for Congress, as filed for insiders

Median delay

execution to disclosure

Last traded

Jun 24

Filed Jun 24

ADViAverage daily dollar volume

$76.8M

market data

Share price · 12M

$40.50 (+0.0%)

Adjusted for splits and dividends.

Volume by month

Buys $5.9M Sells $1.2B

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed

GW Gregory M Weinhoff Chief Business Officer 13 filings SS Saurabh Saha Director 12 filings IH Iqbal J Hussain General Counsel 8 filings MA Mario Alberto Accardi President, Orexin Program 7 filings KA Karen M. Anderson Chief People Officer 7 filings TB Tia L Bush Chief Technology & Quality Ofc 6 filings AG Arjun Goyal Director 1 filing IP Index Ventures Life Vi (jersey) L.P. 10% owner 1 filing

Recent filings

Index Ventures Life Vi (jersey) L.P.SALE 10% owner $403.5M
9,961,789 sh across 2 lots
Exec Jun 24
Filed Jun 24 · 5:30 PM ET Medicxi Ventures Management (Jersey) LtdSALE 10% owner $808.5M
19,963,157 sh across 6 lots
Exec Jun 24
Filed Jun 24 · 5:30 PM ET Karen M. AndersonSALE Chief People Officer $1.2M
41,076 sh × $30.12
Exec Mar 26
Filed Mar 27 · 5:30 PM ET Gregory M WeinhoffSALE Chief Business Officer $720K
23,998 sh × $30.00
Exec Mar 26
Filed Mar 26 · 5:30 PM ET Karen M. AndersonSALE Chief People Officer $2.1M
74,811 sh across 2 lots
Exec Mar 16
Filed Mar 18 · 5:30 PM ET Karen M. AndersonSALE Chief People Officer $3.2M
120,029 sh across 2 lots
Exec Mar 13
Filed Mar 16 · 5:30 PM ET Gregory M WeinhoffSALE Chief Business Officer $1.9M
73,196 sh across 2 lots
Exec Mar 13
Filed Mar 13 · 5:30 PM ET Karen M. AndersonSALE Chief People Officer $3.2M
120,029 sh across 2 lots
Exec Mar 13
Filed Mar 13 · 5:30 PM ET Iqbal J HussainSALE Chief Legal Officer $980K
38,951 sh × $25.15
Exec Feb 2
Filed Feb 3 · 5:30 PM ET Mario Alberto AccardiSALE President, Orexin Program $213K
7,432 sh × $28.70
Exec Dec 9 2025
Filed Dec 9 2025 · 5:30 PM ET Mario Alberto AccardiSALE President, Orexin Program $300K
10,000 sh × $30.00
Exec Dec 8 2025
Filed Dec 8 2025 · 5:30 PM ET Tia L BushSALE Chief Technology & Quality Ofc $1.1M
40,000 sh × $28.00
Exec Nov 17 2025
Filed Nov 18 2025 · 5:30 PM ET Iqbal J HussainSALE General Counsel $166K
6,000 sh × $27.64
Exec Nov 17 2025
Filed Nov 18 2025 · 5:30 PM ET Tia L BushSALE Chief Technology & Quality Ofc $1.0M
40,000 sh × $26.00
Exec Nov 12 2025
Filed Nov 13 2025 · 5:30 PM ET Mario Alberto AccardiSALE President, Orexin Program $200K
8,000 sh × $25.00
Exec Oct 27 2025
Filed Oct 27 2025 · 5:30 PM ET Iqbal J HussainSALE General Counsel $134K
6,000 sh × $22.41
Exec Oct 15 2025
Filed Oct 16 2025 · 5:30 PM ET Tia L BushSALE Chief Technology & Quality Ofc $840K
35,000 sh × $24.00
Exec Sep 24 2025
Filed Sep 24 2025 · 5:30 PM ET Mario Alberto AccardiSALE President, Orexin Program $158K
7,430 sh × $21.33
Exec Sep 16 2025
Filed Sep 16 2025 · 5:30 PM ET Iqbal J HussainSALE General Counsel $131K
6,000 sh × $21.85
Exec Sep 15 2025
Filed Sep 15 2025 · 5:30 PM ET Mario Alberto AccardiSALE President, Orexin Program $140K
7,000 sh × $20.00
Exec Sep 9 2025
Filed Sep 11 2025 · 5:30 PM ET Iqbal J HussainSALE General Counsel $840K
40,000 sh across 2 lots
Exec Sep 9 2025
Filed Sep 11 2025 · 5:30 PM ET Tia L BushSALE Chief Technology & Quality Ofc $1.0M
49,792 sh across 2 lots
Exec Sep 9 2025
Filed Sep 11 2025 · 5:30 PM ET Iqbal J HussainSALE General Counsel $103K
6,000 sh × $17.23
Exec Aug 15 2025
Filed Aug 15 2025 · 5:30 PM ET Mario Alberto AccardiSALE President, Orexin Program $127K
8,322 sh × $15.23
Exec Jul 29 2025
Filed Jul 30 2025 · 5:30 PM ET Gregory M WeinhoffSALE Chief Business Officer $156K
10,000 sh × $15.56
Exec Jul 25 2025
Filed Jul 25 2025 · 5:30 PM ET